Twin Lakes Capital Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1847794
REDWOOD SHORES, CA
Position in REGN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$122,077
-$82,468 QoQ
Shares Held
158
-40.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Twin Lakes Capital Management, LLC holds $2,903,571 across 10 Biotechnology names. REGN ranks #4 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
20,000 | $1,882,400 | |
| 2 | ATHE |
Alterity Therapeutics Ltd
|
139,258 | $484,617 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,554 | $293,783 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
158 | $122,077 | |
| 5 | MRNA |
Moderna, Inc.
|
1,231 | $62,534 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
682 | $32,442 | |
| 7 | VIR |
Vir Biotechnology, Inc.
|
2,195 | $19,667 | |
| 8 | EDIT |
Editas Medicine, Inc.
|
1,250 | $3,087 |
All Filings in REGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $122,077 | 158 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $204,545 | 265 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $149,001 | 265 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $140,175 | 267 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $168,705 | 266 | Shares | Sole | 2025-05-23 | |
| 2024-12-31 | $189,479 | 266 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $279,629 | 266 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $279,573 | 266 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $256,022 | 266 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $233,625 | 266 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $218,907 | 266 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $191,131 | 266 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $239,105 | 291 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $209,953 | 291 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $200,461 | 291 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $172,018 | 291 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $203,240 | 291 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $174,299 | 276 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $175,502 | 290 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $182,642 | 327 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $186,417 | 394 | Shares | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||